{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:42:27Z","timestamp":1791830547618,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/bf03027400","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T23:58:46Z","timestamp":1233532726000},"page":"367-372","source":"Crossref","is-referenced-by-count":6,"title":["Assessment of therapeutic effect in patients with secondary hyperparathyroidism using bone scintigraphy"],"prefix":"10.1007","volume":"19","author":[{"given":"Hayato","family":"Kaida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenkichi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hiromatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naofumi","family":"Hayabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03027400_CR1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/ndt\/17.5.723","volume":"17","author":"F Locatelli","year":"2002","unstructured":"Locatelli F, Cannata-Andia JB, Drueke TB, Horl WH, Fouque D, Heimburger O, et al. Management of disturbance of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyper-phosphataemia.Nephrol Dial Transplant 2002; 17:723\u2013731.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03027400_CR2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9629(15)40552-X","volume":"17","author":"Y. Tominaga","year":"1999","unstructured":"Tominaga Y. Surgical management of secondary hyperparathyroidism in uremia.Am J Med Sci 1999; 17:390\u2013397.","journal-title":"Am J Med Sci"},{"issue":"suppl 1","key":"BF03027400_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0753-3322(00)80007-4","volume":"54","author":"Y. Tominaga","year":"2000","unstructured":"Tominaga Y. Management of renal hyperparathyroidism.Biomed & Pharmacother 2000; 54 (suppl 1); 25\u201331.","journal-title":"Biomed & Pharmacother"},{"key":"BF03027400_CR4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1523-1755.2002.00450.x","volume":"62","author":"HH Malluche","year":"2002","unstructured":"Malluche HH, Mawad H, Koszewski NJ. Update on vitamin D and its newer analogues; actions and rationale for treatment in chronic renal failure.Kidney Int 2002; 62:367\u2013374.","journal-title":"Kidney Int"},{"key":"BF03027400_CR5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1523-1755.1999.055003821.x","volume":"55","author":"MC Monier-Faugere","year":"1999","unstructured":"Monier-Faugere MC, Geng Z, Friedler RM, Qi Q, Kubodera N, Slatopolsky E, et al. 22-Oxacalcitoriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.Kidney Int 1999; 55:821\u2013832.","journal-title":"Kidney Int"},{"issue":"suppl 10","key":"BF03027400_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ndt\/17.suppl_10.6","volume":"17","author":"HH Malluche","year":"2002","unstructured":"Malluche HH, Monier-Faugere MC, Koszewski NJ. Use and indication of vitamin D and vitamin D analogue in patients with renal bone disease.Nephrol Dial Transplant 2002; 17 (suppl 10):6\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03027400_CR7","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","volume":"55","author":"P Urena","year":"1999","unstructured":"Urena P, de Vernejoul MC. Circulating biochemical markers of bone remodeling in uremic patients.Kidney Int 1999; 55:2141\u20132156.","journal-title":"Kidney Int"},{"key":"BF03027400_CR8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0272-6386(03)00197-5","volume":"41","author":"AR Bervoets","year":"2003","unstructured":"Bervoets AR, Spasovski GB, Behets GJ, Dams G, Polenakovic MH, Zafirovska K, et al. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.Am J Kidney Dis 2003; 41:997\u20131007.","journal-title":"Am J Kidney Dis"},{"key":"BF03027400_CR9","first-page":"93","volume":"6","author":"I Fogelman","year":"1981","unstructured":"Fogelman I, Bessent RG, Gordon D. A critical assessment of bone scans quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease.Eur J Nucl Med 1981; 6:93\u201397.","journal-title":"Eur J Nucl Med"},{"key":"BF03027400_CR10","first-page":"1614","volume":"39","author":"O Israel","year":"1998","unstructured":"Israel O, Gips S, Lubushitzky R, Bettman L, Iosilevsky G, Hardoff R, et al. Prediction of bone loss in patients with primary hyperparathyroidism using quantitative boneSPECT. J Nucl Med 1998; 39:1614\u20131617.","journal-title":"J Nucl Med"},{"key":"BF03027400_CR11","first-page":"231","volume":"18","author":"T Wiegmann","year":"1977","unstructured":"Wiegmann T, Rosenthall L, Kaye M. Technetium-99m-pyrophosphate bone scans in hyperparathyroidism.J Nucl Med 1977; 18:231\u2013235.","journal-title":"J Nucl Med"},{"key":"BF03027400_CR12","first-page":"245","volume":"19","author":"I Fogelman","year":"1978","unstructured":"Fogelman I, Bessent RG, Turner JG, Citrin DL, Boyle IT, Greig WR. The use of whole-body retention of99mTc-diphosphonate in the diagnosis of metabolic bone disease.J Nucl Med 1978; 19:245\u2013248.","journal-title":"J Nucl Med"},{"key":"BF03027400_CR13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF02984569","volume":"18","author":"S Kurata","year":"2004","unstructured":"Kurata S, Ishibashi M, Nishida H, Hiromatsu Y, Hayabuchi N. A clinical assessment of the relationship between bone scintigraphy and serum biochemical markers in hemodialysis patients.Ann Nucl Med 2004; 18:513\u2013518.","journal-title":"Ann Nucl Med"},{"issue":"suppl 10","key":"BF03027400_CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ndt\/17.suppl_10.28","volume":"17","author":"T Akizawa","year":"2002","unstructured":"Akizawa T, Suzuki M, Akiba T, Nishizawa Y, Ohashi Y, Ogata E, et al. Long-term effect of 1,25-dihydroxy-22-oxavitamin D3 on secondary hyperparathyroidism in haemodialysis patients, one year administration study.Nephrol Dial Transplant 2002; 17 (suppl 10):28\u201336.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03027400_CR15","first-page":"458","volume":"28","author":"Krauss D Brecht","year":"1987","unstructured":"Brecht Krauss D, Kusmierek J, Hellwig D, Adam WE. Quantitative bone scintigraphy in patients with hyperparathyroidism.J Nucl Med 1987; 28:458\u2013461.","journal-title":"J Nucl Med"},{"key":"BF03027400_CR16","first-page":"543","volume-title":"Bone Biodynamics","author":"LC Johnson","year":"1964","unstructured":"Johnson LC. Morphologic analysis in pathology: the kinetics of disease and general biology of bone. In:Bone Biodynamics, Frost HM, ed, 1st ed. Boston; Little, Brown & Co., 1964:543\u2013654.","edition":"1st ed"},{"key":"BF03027400_CR17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/oxfordjournals.ndt.a027302","volume":"11","author":"H Schmidt-Gayk","year":"1996","unstructured":"Schmidt-Gayk H, Drueke T, Ritz E. Non-invasive circulating indicators of bone metabolism in uraemic patients: can they replace bone biopsy?Nephrol Dial Transplant 1996; 11:415\u2013418.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03027400_CR18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","volume":"7","author":"P Urena","year":"1996","unstructured":"Urena P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC. Plasma total versus bone alkaline phosphatase as markers of turnover in hemodialysis patients.J Am Soc Nephrol 1996; 7:506\u2013512.","journal-title":"J Am Soc Nephrol"},{"key":"BF03027400_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0009-8981(95)06012-8","volume":"235","author":"T Niwa","year":"1995","unstructured":"Niwa T, Shiobara K, Hamada T, Miyazaki T, Tsukushi S, Uema K, et al. Serum pyridinolines as specific markers of bone resorption in hemodialyzed patients.Clin Chemica Acta 1995; 235:33\u201340.","journal-title":"Clin Chemica Acta"},{"key":"BF03027400_CR20","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1681\/ASN.V971225","volume":"9","author":"HC Schober","year":"1988","unstructured":"Schober HC, Han ZH, Foldes AJ, Shin MS, Rao DS, Balena R, et al. Mineralized bone loss at different sites in dialysis patients. Implication for prevention.J Am Soc Nephrol 1988; 9:1225\u20131233.","journal-title":"J Am Soc Nephrol"},{"key":"BF03027400_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000168600","volume":"13","author":"C Gabey","year":"1993","unstructured":"Gabey C, Ruedin P, Slosman D, Bonjour JP, Leski M, Rizzoli R. Bone mineral density in patients with end-stage renal failure.Am J Nephrol 1993; 13:115\u2013123.","journal-title":"Am J Nephrol"},{"key":"BF03027400_CR22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(00)70198-3","volume":"41","author":"Y Tsukamoto","year":"2000","unstructured":"Tsukamoto Y, Hanaoka M, Matsuo T, Saruta T, Nomura M, Takahashi Y. Effect of 22-Oxacalcitoriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism.Am J Kidney Dis 2000; 41:458\u2013464.","journal-title":"Am J Kidney Dis"},{"issue":"suppl 3","key":"BF03027400_CR23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/11.supp3.121","volume":"11","author":"K Kurokawa","year":"1996","unstructured":"Kurokawa K, Akizawa T, Suzuki M, Akiba T, Ogata E, Slatopolsky E. Effect of 22-Oxacalcitoriol on hyperparathyroidism of dialysis patients: result of a preliminary study.Nephrol Dial Transplant 1996; 11 (suppl 3):121\u2013124.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03027400_CR24","first-page":"33","volume":"16","author":"L Rosenthall","year":"1975","unstructured":"Rosenthall L, Kaye M. Technetium-99m-pyrophosphate kinetics and imaging in metabolic bone disease.J Nucl Med 1975; 16:33\u201339.","journal-title":"J Nucl Med"},{"key":"BF03027400_CR25","first-page":"330","volume":"19","author":"RA Holmes","year":"1978","unstructured":"Holmes RA. Quantification of skeletal Tc-99m labeled phosphates to detect metabolic bone disease.J Nucl Med 1978; 19:330\u2013331.","journal-title":"J Nucl Med"},{"key":"BF03027400_CR26","first-page":"509","volume":"6","author":"JFK Lien","year":"1976","unstructured":"Lien JFK, Wiegmann T, Rosenthall L, Kaye M. Abnormal 99m-technetium-tin pyrophosphate bone scans in chronic renal failure.Clin Nephrol 1976; 6:509\u2013512.","journal-title":"Clin Nephrol"},{"key":"BF03027400_CR27","first-page":"77","volume-title":"The Osteoporotic Syndrome","author":"CH Chesnut","year":"1991","unstructured":"Chesnut CH. Noninvasive methods for bone mass measurement. In:The Osteoporotic Syndrome, Avioli LV, ed, 3rd ed. New York; Grune&Stratton, 1991: 77\u201387.","edition":"3rd ed."}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03027400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03027400\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03027400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T23:25:13Z","timestamp":1633044313000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03027400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["BF03027400"],"URL":"https:\/\/doi.org\/10.1007\/bf03027400","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}